| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |